Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

REPCF

RepliCel Life Sciences (CE) (REPCF)

RepliCel Life Sciences Inc (CE)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:REPCF
일자시간출처헤드라인심볼기업
2023/12/0103:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/10/2500:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/10/2002:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/10/0503:23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/09/0801:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/08/3106:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/08/3002:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/08/1800:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/05/3119:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/05/1902:59Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/04/2102:04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/03/1703:40Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/02/0820:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/02/0220:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/01/2700:51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/01/2620:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/01/1802:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/01/1801:48Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/01/0620:02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/12/0920:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/10/2601:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/09/2919:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/09/1319:01Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/09/0703:36Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/08/0500:41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/07/2903:53Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/07/2702:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/07/0802:44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/07/0100:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/06/2919:02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:REPCFRepliCel Life Sciences Inc (CE)
 검색 관련기사 보기:USOTC:REPCF

최근 히스토리

Delayed Upgrade Clock